Table 1.
COVID-19 Patients Admitted to Internal Medicine or Medical Intensive Care Unit Teams from March 1 to May 15, 2020
| Characteristic | COVID-19–Positive Patients (N = 131), No. (%) |
|---|---|
| Sex, female | 52 (39.7) |
| Age, mean y (SD), | 56.0 (17.4) |
| BMI, mean (SD)a | 29.6 (6.3) |
| Time to admission from COVID-19 test, mean d (SD) | 1.7 (3.0) |
| Received antibiotics | 86 (65.6) |
| Antibiotic duration post-COVID-19 result, mean d (SD)b | 4.4 (3.5) |
| MICU care | 43 (32.8) |
| Other documented infectionc | 15 (12.2) |
| Dementia | 8 (6.1) |
| Smoking history | 4 (3.1) |
| Cancer | 11 (8.4) |
| Sepsis or shock | 12 (9.2) |
| Stroke history | 7 (5.3) |
| Death | 13 (9.9) |
| Hepatitis, current or historyd | 23 (17.6) |
| Substance abusee | 6 (4.6%) |
| Cardiovascular problems, chronicf | 66 (50.4) |
| Pulmonary problems, chronicg | 22 (16.8) |
| Immunocompromisedh | 9 (6.9) |
| Acute respiratory issuesi | 54 (41.2) |
| Metabolic problem, chronicj | 49 (37.4) |
| Renal problem, acute or chronick | 24 (18.3) |
Note. SD, standard deviation; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); MICU, medical intensive care unit.
In kg/m2 (n=24).
Mean antibiotic duration calculated for those who received any antibiotic (n=86).
Includes cellulitis, abscess, osteomyelitis, bacteremia, urinary tract infection, endophthalmitis.
Includes current and history of hepatitis A, B or C, alcoholic and nonalcoholic hepatitis, and elevated transaminases.
Includes drug and alcohol abuse.
Includes hypertension, arrythmia other than sinus tachycardia or sinus bradycardia, congestive heart failure, and coronary artery disease.
Includes asthma, chronic obstructive pulmonary disease, and obstructive sleep apnea.
Includes human immunodeficiency virus, chronic variable immune deficiency, hypogammaglobulinemia, history of organ transplant and rheumatological diseases including lupus and rheumatoid arthritis for which immunosuppression is used.
Includes documented hypoxia, dyspnea or tachypnea without respiratory failure and documented respiratory failure.
Includes diabetes, prediabetes, and hyperlipidemia or hypercholesterolemia.
Includes acute renal injury, chronic kidney diseases, and end-stage renal disease with or without dialysis.